GuangYuYuan Chinese Herbal Medicine Co., Ltd. (600771.SS)
CNY 19.33
(1.52%)
CNY 19.33
(1.52%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 90.07 Million CNY | 121.56% |
| 2022 | -417.85 Million CNY | -25.7% |
| 2021 | -332.42 Million CNY | -1138.75% |
| 2020 | 32 Million CNY | -75.4% |
| 2019 | 130.06 Million CNY | -65.23% |
| 2018 | 374.1 Million CNY | 57.98% |
| 2017 | 236.8 Million CNY | 92.82% |
| 2016 | 122.81 Million CNY | 5948.84% |
| 2015 | 2.03 Million CNY | -94.46% |
| 2014 | 36.64 Million CNY | 287.32% |
| 2013 | -19.56 Million CNY | -105.5% |
| 2012 | 355.57 Million CNY | 18.64% |
| 2011 | 299.71 Million CNY | 54.79% |
| 2010 | 193.62 Million CNY | 231.15% |
| 2009 | -147.64 Million CNY | -144.57% |
| 2008 | 331.24 Million CNY | 143.11% |
| 2007 | -768.34 Million CNY | -6187.17% |
| 2006 | 12.62 Million CNY | -64.25% |
| 2005 | 35.3 Million CNY | 17.25% |
| 2004 | 30.11 Million CNY | -21.99% |
| 2003 | 38.59 Million CNY | 3.67% |
| 2002 | 37.23 Million CNY | -8.68% |
| 2001 | 40.76 Million CNY | -23.31% |
| 2000 | 53.15 Million CNY | 85.71% |
| 1999 | 28.62 Million CNY | 152.64% |
| 1998 | 11.32 Million CNY | -11.66% |
| 1997 | 12.82 Million CNY | 7.37% |
| 1996 | 11.94 Million CNY | 12.12% |
| 1995 | 10.65 Million CNY | 260.6% |
| 1994 | 2.95 Million CNY | 8.22% |
| 1993 | 2.72 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 18.29 Million CNY | -55.7% |
| 2024 Q1 | 41.3 Million CNY | 2905.5% |
| 2024 Q3 | 11.36 Million CNY | -37.92% |
| 2023 Q4 | -1.47 Million CNY | -110.21% |
| 2023 Q1 | 9.79 Million CNY | 102.69% |
| 2023 FY | 90.07 Million CNY | 121.56% |
| 2023 Q2 | 273.61 Thousand CNY | -97.21% |
| 2023 Q3 | 14.42 Million CNY | 5171.31% |
| 2022 Q3 | -60.48 Million CNY | -7469.13% |
| 2022 Q2 | -799.16 Thousand CNY | -110.3% |
| 2022 Q1 | 7.75 Million CNY | 103.77% |
| 2022 Q4 | -364.03 Million CNY | -501.81% |
| 2022 FY | -417.85 Million CNY | -25.7% |
| 2021 Q4 | -205.51 Million CNY | -228.04% |
| 2021 Q1 | 5.16 Million CNY | 115.74% |
| 2021 Q3 | -62.64 Million CNY | -17.64% |
| 2021 FY | -332.42 Million CNY | -1138.75% |
| 2021 Q2 | -53.25 Million CNY | -1130.08% |
| 2020 Q3 | 21.4 Million CNY | 34.88% |
| 2020 FY | 32 Million CNY | -75.4% |
| 2020 Q1 | 27.57 Million CNY | 163.04% |
| 2020 Q2 | 15.86 Million CNY | -42.45% |
| 2020 Q4 | -32.83 Million CNY | -253.44% |
| 2019 FY | 130.06 Million CNY | -65.23% |
| 2019 Q1 | 57.31 Million CNY | -61.31% |
| 2019 Q2 | 59.96 Million CNY | 4.63% |
| 2019 Q4 | -43.73 Million CNY | -177.38% |
| 2019 Q3 | 56.52 Million CNY | -5.74% |
| 2018 Q4 | 148.12 Million CNY | 81.24% |
| 2018 Q2 | 92.6 Million CNY | 79.33% |
| 2018 FY | 374.1 Million CNY | 57.98% |
| 2018 Q1 | 51.64 Million CNY | -61.23% |
| 2018 Q3 | 81.72 Million CNY | -11.75% |
| 2017 FY | 236.8 Million CNY | 92.82% |
| 2017 Q4 | 133.21 Million CNY | 434.6% |
| 2017 Q3 | 24.91 Million CNY | -54.22% |
| 2017 Q2 | 54.42 Million CNY | 124.44% |
| 2017 Q1 | 24.25 Million CNY | -68.81% |
| 2016 Q3 | 23.54 Million CNY | 75.26% |
| 2016 Q2 | 13.43 Million CNY | 66.0% |
| 2016 Q4 | 77.73 Million CNY | 230.19% |
| 2016 Q1 | 8.09 Million CNY | 824.73% |
| 2016 FY | 122.81 Million CNY | 5948.84% |
| 2015 FY | 2.03 Million CNY | -94.46% |
| 2015 Q2 | 1.93 Million CNY | 266.23% |
| 2015 Q4 | 875.12 Thousand CNY | 128.23% |
| 2015 Q3 | 383.44 Thousand CNY | -80.2% |
| 2015 Q1 | -1.16 Million CNY | -103.35% |
| 2014 Q2 | 12.15 Million CNY | 244.91% |
| 2014 Q1 | -8.38 Million CNY | 59.24% |
| 2014 FY | 36.64 Million CNY | 287.32% |
| 2014 Q4 | 34.77 Million CNY | 1933.61% |
| 2014 Q3 | -1.89 Million CNY | -115.6% |
| 2013 Q4 | -20.58 Million CNY | -160.96% |
| 2013 FY | -19.56 Million CNY | -105.5% |
| 2013 Q3 | -7.88 Million CNY | -195.48% |
| 2013 Q2 | 8.26 Million CNY | 1182.36% |
| 2013 Q1 | 644.14 Thousand CNY | -99.85% |
| 2012 FY | 355.57 Million CNY | 18.64% |
| 2012 Q2 | -35.15 Million CNY | -113.11% |
| 2012 Q3 | -17.84 Million CNY | 49.23% |
| 2012 Q4 | 425.06 Million CNY | 2481.81% |
| 2012 Q1 | -16.49 Million CNY | -469.08% |
| 2011 Q2 | 119.64 Million CNY | 56.54% |
| 2011 Q1 | 76.43 Million CNY | -71.08% |
| 2011 Q3 | 99.16 Million CNY | -17.12% |
| 2011 Q4 | 4.46 Million CNY | -95.49% |
| 2011 FY | 299.71 Million CNY | 54.79% |
| 2010 Q1 | -18.49 Million CNY | 55.36% |
| 2010 Q2 | -26.11 Million CNY | -41.16% |
| 2010 Q3 | -26.07 Million CNY | 0.16% |
| 2010 Q4 | 264.31 Million CNY | 1113.78% |
| 2010 FY | 193.62 Million CNY | 231.15% |
| 2009 FY | -147.64 Million CNY | -144.57% |
| 2009 Q1 | -18.66 Million CNY | -255.96% |
| 2009 Q2 | -46.57 Million CNY | -149.49% |
| 2009 Q3 | -40.95 Million CNY | 12.07% |
| 2009 Q4 | -41.43 Million CNY | -1.18% |
| 2008 Q3 | 331.18 Million CNY | 7934.98% |
| 2008 Q4 | -5.24 Million CNY | -101.58% |
| 2008 Q2 | 4.12 Million CNY | 246.15% |
| 2008 Q1 | 1.19 Million CNY | 100.15% |
| 2008 FY | 331.24 Million CNY | 143.11% |
| 2007 FY | -768.34 Million CNY | -6187.17% |
| 2007 Q2 | 5.21 Million CNY | -28.8% |
| 2007 Q1 | 7.31 Million CNY | 282.5% |
| 2007 Q3 | -4.51 Million CNY | -186.59% |
| 2007 Q4 | -776.35 Million CNY | -17107.69% |
| 2006 Q1 | 14.61 Million CNY | 176.84% |
| 2006 Q4 | -4 Million CNY | 2.34% |
| 2006 Q3 | -4.1 Million CNY | -167.08% |
| 2006 Q2 | 6.12 Million CNY | -58.12% |
| 2006 FY | 12.62 Million CNY | -64.25% |
| 2005 Q2 | 1.13 Million CNY | -93.71% |
| 2005 FY | 35.3 Million CNY | 17.25% |
| 2005 Q1 | 18.04 Million CNY | 289.3% |
| 2005 Q3 | 10.84 Million CNY | 855.13% |
| 2005 Q4 | 5.27 Million CNY | -51.31% |
| 2004 Q2 | 12.22 Million CNY | -32.61% |
| 2004 Q1 | 18.13 Million CNY | 190.99% |
| 2004 FY | 30.11 Million CNY | -21.99% |
| 2004 Q4 | -9.53 Million CNY | -202.63% |
| 2004 Q3 | 9.28 Million CNY | -23.99% |
| 2003 Q2 | 9.83 Million CNY | -36.96% |
| 2003 FY | 38.59 Million CNY | 3.67% |
| 2003 Q1 | 15.59 Million CNY | 9.31% |
| 2003 Q4 | 6.23 Million CNY | -10.19% |
| 2003 Q3 | 6.93 Million CNY | -29.43% |
| 2002 Q2 | 10.15 Million CNY | 27.06% |
| 2002 FY | 37.23 Million CNY | -8.68% |
| 2002 Q3 | 4.81 Million CNY | -52.56% |
| 2002 Q4 | 14.26 Million CNY | 196.17% |
| 2002 Q1 | 7.99 Million CNY | 0.0% |
| 2001 FY | 40.76 Million CNY | -23.31% |
| 2000 FY | 53.15 Million CNY | 85.71% |
| 1999 FY | 28.62 Million CNY | 152.64% |
| 1998 FY | 11.32 Million CNY | -11.66% |
| 1997 FY | 12.82 Million CNY | 7.37% |
| 1996 FY | 11.94 Million CNY | 12.12% |
| 1995 FY | 10.65 Million CNY | 260.6% |
| 1994 FY | 2.95 Million CNY | 8.22% |
| 1993 FY | 2.72 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 4.3 Billion CNY | 97.906% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 2.79 Billion CNY | 96.78% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 591.57 Million CNY | 84.773% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 57 Million CNY | -58.031% |
| Aurora Optoelectronics Co.,Ltd. | -675.27 Million CNY | 113.339% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -38.27 Million CNY | 335.345% |
| NanJing Pharmaceutical Company Limited | 577.82 Million CNY | 84.411% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.16 Billion CNY | 92.287% |